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Abstract
Oncocytic metaplasia (OM) is not a well-known feature in inflammatory fibrous hyperplasia (IFH) lesions, although 
it may be common, as proposed in our previous study about this lesion. In the present paper, we assessed the histopa-
thological and immunohistochemical features of 18 cases of IFH containing OM areas. All the samples were examined 
on haematoxylin and eosin stained sections and cytokeratins (AE1/AE3, 34ßE12, CK5, CK7, CK8, CK13, CK14 and 
CK19), CD15, CD20, CD68, CD45Ro, and LCA primary antibodies were used. The vast majority of IFH occurred 
in women (n=14) and the most common site of presentation was the buccal vestibule. Oncocytic and salivary duct 
cells showed uniform immunoreactivity for AE1/AE3, CK7, CK8 and CK19. CD45Ro+ T-lymphocytes were the 
most common inflammatory cells surrounding the OM areas followed by CD20+ B-lymphocytes. These findings 
suggest that oncocytic cells present in IFH might develop from salivary duct epithelium, and T-lymphocytes might 
play an important role in its etiopathogenesis. 
Key words: Oncocytic metaplasia, inflammatory fibrous hyperplasia, immunohistochemical, histopathology, T-lympho-
cytes.
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Introduction
Inflammatory fibrous hyperplasia (IFH), also called 
denture-induced fibrous hyperplasia and epulis fissuratum, 
is the most common lesion of the oral mucosa, usually 
associated to an ill-fitting denture (1). This lesion is easily 
recognised and in some cases distinct microscopic varia-
tions such as osseous, oncocytic and squamous metaplasia 
may be found. It is caused by chronic trauma generated 
by ill-fitting denture, where denture edges contact the 
adjacent tissue (2). 
Oncocytic metaplasia (OM) is a well-documented feature 
in the major salivary glands, which mainly affects elderly 
patients (3). OM has also been reported in minor salivary 
glands, particularly in the larynx and pharynx (3-5). 
However, its occurrence in IFH is poorly documented 
(6, 7). Oncocytic cells may develop from duct cells but its 
source is still debatable (3). 
The aim of this study was to determine the histopatho-
logical and immunohistochemical (IHC) features of OM 
areas in IFH, in order to better understand their etiopa-
thogenesis and to characterize the cellular inflammatory 
infiltrate present around these areas.  
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Patients and Methods
- Clinical data 
Archived formalin-fixed, paraffin-embedded tissue blocks 
of 18 cases of IFH with OM areas were obtained from 
the Oral Pathology Section, Piracicaba Dental School, 
UNICAMP-Brazil. Clinical data were collected from the 
clinical charts. All the samples were examined on hae-
matoxylin and eosin (H&E) stained sections. The study 
was approved by the Piracicaba Dental School Research 
Ethics Committee.
In a total of eighteen patients, fourteen were female and 
four male, with a mean age of 64.3± 9.3 years (range from 
47 to 82 years). IFHs were present in the oral cavity from 
several months to 5 years before the surgical excision. 
Clinically, all lesions presented as submucosal nodules 
(average size: 0.5 to 6 cm in the maximum diameter), and 
the most common site of presentation was the vestibular 
sulcus (9 cases), followed by the alveolar ridge (5 cases), 
buccal mucosa (2 cases), and floor of the mouth (2 cases) 
(Fig. 1). All cases were treated by complete surgical exci-
sion and no recurrences have been detected. 
- IHC  and histomorphometric analysis
Immunostaining was performed on 3µm paraffin sections 
and mounted onto coated-xylan slides. Sections were 
deparaffinized and rehydrated. Endogenous peroxidase 
activity was blocked by quenching the sections in 3% 
hydrogen peroxide. The antigen retrieval was performed 
using citrate-phosphate buffer pH6 in a microwave oven. 
Next, the samples were incubated with the primary an-
tibody as described on the Table 1, using appropriate 
positive and negative controls, and biotynilated secondary 
antibodies conjugated with streptavidin-biotin-peroxidase 
(StreptABComplex/HRP Duet, Mouse/Rabbit, Dako A/S, 
Denmark), which were revealed using the diaminobenzidi-
ne chromogen solution, and counterstained with Carazzi’s 
haematoxylin. The immunoreactivity was classified as 
positive or negative. 
The OM areas and residual minor salivary gland tissues 
were assessed to determine the cytokeratins (CK) profile. 
The immunoreactivity of  inflammatory cells present 
around the OM areas was assessed by counting of positive 
cells in 10 fields of 21 208.57 μm2 (System KS-400 2.1 
version), establishing, if  necessary, an average between 
them.
- Statistical analysis 
Relationships between data of  inflammatory cells su-
rrounding the OM areas were analyzed using a two-tailed 
T test. A p value below 0.05 was considered statistically 
significant.
Results
- Histopathological findings
All the cases showed focal (n=6) or multiple (n=12) 
Antibody Source/Clone
Dilution Antigen 
retrieval
Broad spectrum CK Dako1, AE1/AE3 1:500 Mw
CK5 Novocastra2, XM26 1:400 Mw
CK7 Dako, OV-TL12/30 1:400 Mw
CK8 Dako, 35βH11 1:200 Mw
CK13 Novocastra, KS-1AE 1:400 Mw
CK14 Novocastra, NCL-L-LL002 1:200 Mw
CK19 Dako, RCK108 1:400 Mw
HMW-CK Dako, 34βE12 1:200 Mw
CD15 Dako, C3D-1 1:200 Mw
CD20 (B-cells) Dako, L26 1:10000 Mw
CD68 (macrophages) Dako, PG-M1 1:400 Mw
CD45RO (T cells) Dako, UCHL1 1:200 Mw
LCA Dako, PD7/26/16E2B11 1:2000 Mw
Fig. 1. Nodular mass (IFH) located in the anterior maxillary 
vestibular sulcus. 
Table 1. Primary antibodies, sources and protocols used in the present study.
1Dako A/S, Denmark; 2Novocastra Laboratories, UK; CK: cytokeratins; Mw: microwave; LCA: leu-
kocyte common antigen; HMW: high molecular weight.       
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Fig. 2. OM area displaying intraluminal papillary projec-
tions associated to chronic inflammatory infiltrate (H&E, 
OM X10).
Fig. 3.  Intense immunoreactivity for AE1/AE3 in the 
luminal and non-luminal cells (OM X20).
Fig. 4. Basal cells located at the periphery of the OM area 
showing intense reactivity for CK5 (OM X20).
Fig. 5. Oncocytic luminal cells showing intense immuno-
reactivity for CK7 (OM X40).
Fig. 6. OM area showing cellular inflammatory infiltrate 
richly composed by CD45Ro+ T-lymphocytes (OM X20).
Fig. 7. Nodular aggregate of CD20+ B-lymphocytes around 
OM area (OM X20).
Fig. 8. Scarce CD68+ macrophages adjacent 
to OM area (OM X40).
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OM areas. In these latter, it was detected 2 to 14 OM 
areas (mean of 4,8 per case), and intraluminal papillary 
projections surrounded or not by cellular inflammatory 
infiltrate (Fig. 2), which simulated a cystadenoma (n=3) 
or Warthin´s tumour (n=2), were found. Fourteen cases 
showed well-defined double-layered oncocytic epithelium 
areas. Moreover, inflammatory cells and scarce secondary 
lymphoid follicles (1 to 5) were seen adjacent to the surface 
epithelium in 7 cases.
- IHC study
CK immunoreactivity in the OM areas and adjacent nor-
mal minor salivary glands.
AE1/AE3 was uniformly expressed in the luminal, basal 
and myoepithelial cells of  the normal minor salivary 
glands, and in the luminal and basal cells of OM areas 
(Fig. 3). The myoepithelial and basal cells of the striated 
and excretory ducts of normal minor salivary glands and 
the basal cells of OM areas were positive for CK34ßE12, 
CK5, and CK14  (Fig. 4). The luminal cells of the striated 
and excretory ducts of normal minor salivary glands and 
OM areas were positive for CK7, CK8, and CK19 (Fig. 
5). The CK13 was uniformly negative in all normal minor 
salivary glands and OM areas. All mucous acini were 
negative for these markers.
- Inflammatory infiltrate characterization around OM 
areas
Intense immunoreactivity for leukocyte common antigen 
(LCA) was seen in the cellular inflammatory infiltrate 
encircling the OM areas and adjacent to the surface epi-
thelium. CD45Ro+ T-lymphocytes were the most common 
cells (Fig. 6), and only 4 cases showed predominance of 
CD20+ B-lymphocytes. Seven cases displayed secondary 
lymphoid follicles (1 to 5) adjacent to the surface epithe-
lium (Fig. 7). CD68 immunoreactivity was found adjacent 
to the surface epithelium and microulcerated areas (Fig. 
8). CD15+ granulocytic cells were sporadically detected 
on both microulcerated and perivascular areas. 
The number of CD45Ro+ T-lymphocytes was significantly 
higher than CD20+ B-lymphocytes (p<0.041), CD68+ 
macrophages (p<0.0005), and CD15+ granulocytic 
cells (p<0.00001). In addition, the number of  CD20+ 
B-lymphocytes was significantly greater than CD68+ 
macrophages (p=0.1876) and CD15+ granulocytic cells 
(p=0.0135) (Fig. 9).
Discussion
IFH is caused by chronic trauma produced by partial or 
total ill-fitting denture (2, 8). It affects predominantly 
women (5:1) in the fifth and sixth decades of life. In our 
study, IFH with OM areas occurred mainly in women 
(3,5:1) in the sixty decade of life, suggesting that the age 
and use of ill-fitting denture might be important clinical 
factors to its occurrence.
Oncocytes are characterized histologically by the presence 
of finely granular eosinophilic cytoplasm resulting from an 
increased number of mitochondria. As oncocytes divide, 
their pathologic metabolic activity and mitochondrial phe-
notype are passed on to their progeny. These cells produce 
tissue lesions that range from focal OM and hyperplasias 
to benign and malignant neoplasms (9). OM is characte-
rized by the replacement of ducts and acini of seromuci-
nous glands by cells with abundant brightly eosinophilic 
granular cytoplasm (10), which can be seen in normal and 
pathological tissues, particularly in parathyroid, salivary, 
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Fig. 9.  Histogram showing the immunoreactivity of inflammatory cells (%) surrounding the OM areas 
(n=18). The CD45Ro+ T-lymphocytes were the most prevalent cells, followed by CD20+ B-lymphocytes, 
CD68+ macrophages and CD15+ granulocytic cells. 
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lachrymal, and mucous glands of the upper aerodigestive 
tract (11). Oncocytic, squamous, and osseous metaplasia 
can be found in IFH, and OM is frequently and directly 
associated with chronic inflammatory infiltrate (7). Our 
results showed that oncocytic changes in IFH might be 
related to inflammation or increased cellular metabolism 
as well as a degenerative phenomenon caused by cellular 
aging (11). We cannot discard that OM could be the res-
ponse to partial duct obstruction of minor salivary glands 
caused by constant pressure from overextended borders 
denture (12). However, their exact significance and the 
biological function are still unknown (10).
The intercalated, striated, and excretory ducts and acinic 
cells of the normal salivary glands are positive for CK7, 
CK8, CK18 and CK19 (13). The myoepithelial cells are 
CK14 positive, while that the basal cells located in the 
striated and excretory ducts are reactive for CK7, CK14 
and CK19 (14,15). The origin of oncocytic cells remains 
controversial. However, most evidences favour a duct 
cell origin, but acinic cell origin has also been proposed 
(3). The IHC profile of the luminal and basal layers of 
Warthin’s tumour showed similar immunoreactivity to 
striated duct and basal epithelial cells of  the parotid 
gland, respectively (14,16). On the other hand, Terada 
and Taniguchi (17), assessing an intraductal oncocytic 
papillary carcinoma of the liver, showed that the luminal 
oncocytic cells were immunoreactive for CK7, CK18 and 
CK19. Recently, we reported a case of denture hyperplasia 
with areas simulating oral inverted ductal papilloma, and 
observed intense immunoreactivity for CK7 and CK14 in 
the luminal and basal cells, respectively (18). Take together, 
we can hypothesize that oncocytic cells seen in IFH could 
derive from salivary duct cells as result of the aggression 
caused by lymphocytic infiltrate, as well as due to the 
constant pressure by overextended denture borders cau-
sing partial salivary duct obstruction. Our IHC findings 
indicate a duct cell origin for these cells, since both cells 
exhibit similar profile for CK7, CK8 and CK19. 
CK expression is almost identical in serous and mucous 
acini (19). As differentiation proceeds, secretory cells 
gradually develop extensive rough endoplasmic reticulum 
then accumulate secretory granules that may lead to the 
displacement of  the intermediate filaments to the cell 
periphery. Thus, the expression of intermediate filaments 
does not depend on the type of secretion granules but may 
rather be related to the number of granules storage (13). 
These features might explain the lack of immunoreactivity 
for CK seen in all the mucous acini of our cases.
van Loon et al. (20) found a high proportion of CD8+ 
T-lymphocytes in the normal human oral mucosa and 
skin, whereas those B-lymphocytes were scarce or rare. 
In our study, the vast majority of OM areas were directly 
associated with lymphocytic infiltrates and CD45Ro+ 
T-lymphocytes were the prevalent cells with occasional 
predominance of CD20+ B-lymphocytes. Such associa-
tion favours that OM areas are reactive lesions, because 
of response to the lymphocytes while trying to increase 
production of high-energy phosphate (9).
In summary, we described the histopathological and IHC 
features of OM areas in IFH. Our results indicate that the 
oncocytic cells seen in the OM areas might develop from 
salivary duct epithelium and T-lymphocytes might play an 
important role in their etiopathogenesis. Further studies 
are needed to confirm our results. 
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